CTLA4 and breast carcinoma: This aligns with findings by Lan et al., who reported that in breast cancer, neither interstitial nor tumor CTLA-4 expression was linked to any clinical parameters, including tumor grade, supporting the lack of significant correlation between CTLA-4 staining patterns and clinicopathological features [12].